SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Figma, Inc. is an AI-powered digital design and product development platform. The firm offers tools for teams to collaborate on the entire lifecycle of software creation. Its products include FigJam, Figma Slides, Figma Design, Figma Draw, Dev Mode, Figma Sites, Figma Buzz and Figma Make. The company was founded by Dylan Joseph Field and Evan Darrow Wallace in 2012 and is headquartered in San Francisco, CA.

Figma Inc. - Ordinary Shares - Class A

Figma

Figma is experiencing significant volatility and social media attention as investors debate its potential for a short squeeze, driven by a high short interest and conflicting views on its valuation versus its enterprise growth. While some community members are betting on a recovery fueled by AI product integration and recent institutional upgrades, others remain skeptical, citing executive insider selling and persistent concerns over the stock's post-IPO performance.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980 and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

Sarepta Therapeutics is experiencing significant stock volatility and investor frustration, driven by the recent appointment of a new CEO and lingering skepticism regarding the company's valuation relative to its Duchenne muscular dystrophy portfolio. Community sentiment is deeply polarized, with many investors pointing to an apparent disconnect between the company's approved therapies and its distressed stock price, leading to intense debates over potential buyout scenarios versus the long-term potential of its siRNA pipeline.

Gorilla Technology Group, Inc. engages in the provision of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology security solutions and services in Asia Pacific. It operates through the following segments: Video IoT, Security Convergence, and Other. The company was founded by Spincer Koh in May 2001 and is headquartered in London, the United Kingdom.

Gorilla Technology Group Inc

Gorilla Technology is facing intense investor scrutiny and heavy selling pressure following a recent convertible note offering aimed at funding major AI infrastructure projects in Southeast Asia. While management emphasizes the long-term potential of these billion-dollar contracted programs, community sentiment remains sharply divided between those viewing the price drop as an aggressive, fear-driven entry opportunity and critics frustrated by repeated dilution and perceived failures in executive communication.

Mobileye Global, Inc. engages in the business of developing and deploying driver assistance systems and autonomous driving technologies and solutions. It operates under the Mobileye and Other segments. The company was founded by Amnon Shashua and Ziv Aviram in 1999 and is headquartered in Jerusalem, Israel.

Mobileye Global Inc - Ordinary Shares - Class A

MOBILEYE GLOBAL INC

Mobileye is facing significant market volatility as investors debate the impact of the CEO's upcoming resignation against a backdrop of positive earnings, raised guidance, and ongoing share buybacks. The community is actively debating the stock's potential for a short squeeze, its long-term positioning in the autonomous driving and robotics sectors, and whether the recent leadership transition signals a pivot toward more aggressive growth or increased uncertainty.

Fermi, Inc. engages in the development of energy infrastructure. It intends to develop an energy and data center development campus to support the needs of to-be-built AI infrastructure. The company was founded by Rick Perry, Toby Neugebauer and Griffin Perry on January 10, 2025 and is headquartered in Amrillo, TX.

Fermi Inc

Fermi LLC

Fermi LLC is trending as investors react to the arrival of major turbine components at the Port of Houston, which serves as a critical milestone for its Project Matador energy campus. The community is actively debating the potential for an imminent anchor tenant agreement, with many pointing to significant executive compensation incentives tied to a late-July signing deadline.

TokenOS is the world’s most advanced AI-powered Web3 development platform, designed to turn natural language prompts into fully functional, production-ready blockchain applications. From simple tokens and memecoins to complex DeFi protocols, TokenOS automates the creation, deployment, and auditing of smart contracts and dApps with enterprise-grade reliability. By combining advanced language models with blockchain infrastructure, TokenOS removes the barriers of technical expertise, making Web3 development accessible to everyone. With instant deployment, built-in security best practices, and cross-chain support on the roadmap, TokenOS empowers entrepreneurs, developers, and creators to launch tokenized businesses and decentralized applications in seconds.

TokenOS AI

TokenOS AI is trending as investors rally behind its v4 launch and a profit-sharing model that distributes decentralized GPU compute revenue to node runners and stakers. The community is focused on the extreme supply scarcity created by over 80% of tokens being locked in long-term staking, fueling discussions about its potential as a high-growth AI infrastructure play.

NuScale Power Corp. provides proprietary and innovative advanced small modular reactor (SMR) nuclear technology, with a mission to help power the global energy transition by delivering safe, scalable, and reliable carbon-free energy. Its products include VOYGR SMR Plants and Energy Exploration (E2) Centers. The company was founded by José N. Reyes in 2007 and is headquartered in Corvallis, OR.

NuScale Power Corporation - Ordinary Shares - Class A

NuScale Power Corp

NuScale Power is seeing heightened investor activity as the broader nuclear energy sector navigates complex regulatory environments and shifting data center power requirements. While some market participants express frustration over delayed contract announcements and long-term timelines, the community remains actively divided between those betting on the long-term potential of small modular reactors and those skeptical of current management execution and sector-wide volatility.

AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. It offers antibody discovery platform that searches, decodes and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease. The company was founded by Carl Lars G. Hensen, Kathleen Lisaingo, Kevin Heyries, Véronique Lecault and Daniel Da Costa on November 8, 2012 and is headquartered in Vancouver, Canada.

AbCellera Biologics Inc

AbCellera Biologics is trending as investors digest significant partnerships, including a recent collaboration with Vertex Pharmaceuticals, which has fueled optimism regarding the platform's long-term validation and commercial potential. While the community is actively debating the company's valuation, clinical data milestones for its internal pipeline, and potential for a short squeeze, sentiment remains divided between long-term holders encouraged by platform growth and skeptics focused on historical stock performance and lack of consistent shareholder returns.

Hedera is a decentralized public network where developers can build secure, fair applications with near real-time consensus. The platform is owned and governed by a council of global innovators including Avery Dennison, Boeing, Deutsche Telekom, DLA Piper, FIS (WorldPay), Google, IBM, LG Electronics, Magalu, Nomura, Swirlds, Tata Communications, University College London (UCL), Wipro, and Zain Group.   The Hedera Consensus Service (HCS) acts as a trust layer for any application or permissioned network and allows for the creation of an immutable and verifiable log of messages. Application messages are submitted to the Hedera network for consensus, given a trusted timestamp, and fairly ordered. Use HCS to track assets across a supply chain, create auditable logs of events in an advertising platform, or even use it as a decentralized ordering service.

Hedera Hashgraph

Hedera Hashgraph is seeing a significant uptick in community sentiment and price activity as investors speculate on its role in the broader institutional tokenization and AI infrastructure landscape. The community is actively debating the potential for long-term utility-driven adoption while monitoring how the asset stacks up against other legacy-integrated crypto projects during current market shifts.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Viking Therapeutics is trending as investors weigh recent board expansion and ongoing clinical pipeline developments against heavy short interest and concerns over long-term capital needs ahead of anticipated maintenance data. The community remains sharply divided, with bulls pointing to the potential of VK2735 as a best-in-class obesity treatment while bears remain focused on the company's cash burn and the lack of a confirmed buyout or partnership.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


myhappify

myhappify